RBPJ is a novel target for rhabdomyosarcoma therapy.
Nagao H, Setoguchi T, Kitamoto S, Ishidou Y, Nagano S, Yokouchi M, Abematsu M, Kawabata N, Maeda S, Yonezawa S, Komiya S.
Nagao H, et al.
PLoS One. 2012;7(7):e39268. doi: 10.1371/journal.pone.0039268. Epub 2012 Jul 9.
PLoS One. 2012.
PMID: 22792167
Free PMC article.